Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 MINDY3 USP17L17 USP17L6P USP17L3 USP17L22 USP15 USP17L15 USP17L8 USP17L13	8.88e-31	114	103	23	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 MINDY3 USP17L17 USP17L6P USP17L3 USP17L22 USP15 USP17L15 USP17L8 USP17L13	7.25e-30	124	103	23	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 MINDY3 USP17L17 USP17L6P USP17L3 USP17L22 USP15 USP17L15 USP17L8 USP17L13	8.51e-29	137	103	23	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 MINDY3 USP17L17 USP17L6P USP17L3 USP17L22 USP15 USP17L15 USP17L8 USP17L13	2.90e-25	192	103	23	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP17L7 USP17L21 RELN USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 ACE2 MINDY3 USP17L17 LNPEP USP17L6P USP17L3 C1S USP17L22 USP15 USP17L15 USP17L8 USP17L13	2.24e-17	654	103	27	GO:0008233
GeneOntologyMolecularFunction	polypeptide N-acetylgalactosaminyltransferase activity	GALNTL6 GALNT10 GALNT3 GALNT6 GALNT4	4.83e-08	20	103	5	GO:0004653
GeneOntologyMolecularFunction	acetylgalactosaminyltransferase activity	GALNTL6 GALNT10 GALNT3 GALNT6 GALNT4	9.51e-07	35	103	5	GO:0008376
GeneOntologyMolecularFunction	taurine binding	SLC6A6 GLRA1	2.64e-05	2	103	2	GO:0030977
GeneOntologyMolecularFunction	alkanesulfonate binding	SLC6A6 GLRA1	2.64e-05	2	103	2	GO:0043210
GeneOntologyMolecularFunction	carbohydrate binding	GALNTL6 GALNT10 GALNT3 PKD1L2 NECTIN1 GPCPD1 GALNT6 GALNT4	2.04e-04	310	103	8	GO:0030246
GeneOntologyMolecularFunction	extracellularly glycine-gated ion channel activity	GLRA3 GLRA1	3.90e-04	6	103	2	GO:0016933
GeneOntologyMolecularFunction	extracellularly glycine-gated chloride channel activity	GLRA3 GLRA1	3.90e-04	6	103	2	GO:0016934
GeneOntologyMolecularFunction	inhibitory extracellular ligand-gated monoatomic ion channel activity	GLRA3 GLRA1	7.23e-04	8	103	2	GO:0005237
GeneOntologyMolecularFunction	UDP-glycosyltransferase activity	GALNTL6 GALNT10 GALNT3 GALNT6 GALNT4	1.18e-03	153	103	5	GO:0008194
GeneOntologyMolecularFunction	calcium ion binding	TPO VSNL1 GALNT3 DGKG PKD1L2 LRP1B MYOF SPOCK3 C1S CDH6 HPCAL4	1.67e-03	749	103	11	GO:0005509
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 MINDY3 USP17L17 USP17L6P USP17L3 USP17L22 USP15 USP17L15 USP17L8 USP17L13	2.40e-28	125	103	22	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 MINDY3 USP17L17 USP17L6P USP17L3 USP17L22 USP15 USP17L15 USP17L8 USP17L13	6.59e-27	144	103	22	GO:0070646
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP17L7 USP17L21 USP17L4 LZTR1 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 ZMIZ1 TRIM52 USP17L18 MINDY3 USP17L17 LNPEP USP17L6P USP17L3 USP17L22 USP15 USP17L15 USP17L8 USP17L13 KLHL17	4.00e-13	1009	103	27	GO:0070647
GeneOntologyBiologicalProcess	post-translational protein modification	USP17L7 USP17L21 USP17L4 LZTR1 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 ZMIZ1 TRIM52 USP17L18 MINDY3 USP17L17 LNPEP USP17L6P USP17L3 USP17L22 USP15 USP17L15 USP17L8 USP17L13 KLHL17	1.73e-12	1074	103	27	GO:0043687
GeneOntologyBiologicalProcess	protein O-linked glycosylation via threonine	GALNTL6 GALNT3 GALNT6 GALNT4	1.20e-07	10	103	4	GO:0018243
GeneOntologyBiologicalProcess	O-glycan processing	GALNT10 GALNT3 GALNT6 GALNT4	6.23e-05	43	103	4	GO:0016266
GeneOntologyBiologicalProcess	adult walking behavior	CACNA1A CACNA1C GLRA1 ABHD12	1.13e-04	50	103	4	GO:0007628
GeneOntologyBiologicalProcess	regulation of hormone levels	FOXE1 TPO CACNA1A CACNA1C RELN VSNL1 ABCA12 TIPARP TUBB1 ACE2 FGB FOXD1	1.56e-04	684	103	12	GO:0010817
GeneOntologyBiologicalProcess	protein O-linked glycosylation	GALNTL6 GALNT10 GALNT3 GALNT6 GALNT4	1.83e-04	105	103	5	GO:0006493
GeneOntologyBiologicalProcess	walking behavior	CACNA1A CACNA1C GLRA1 ABHD12	2.31e-04	60	103	4	GO:0090659
GeneOntologyBiologicalProcess	synaptic transmission, glycinergic	GLRA1 SLC7A10	2.45e-04	5	103	2	GO:0060012
GeneOntologyCellularComponent	endoplasmic reticulum membrane	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 ATP10B USP17L10 USP17L19 PPP1R15A USP17L18 USP17L17 CYB5R3 USP17L6P USP17L3 USP17L22 ABHD12 USP17L15 USP17L8 USP17L13	2.67e-08	1293	99	23	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 ATP10B USP17L10 USP17L19 PPP1R15A USP17L18 USP17L17 CYB5R3 USP17L6P USP17L3 USP17L22 ABHD12 USP17L15 USP17L8 USP17L13	2.91e-08	1299	99	23	GO:0098827
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 ATP10B USP17L10 USP17L19 PPP1R15A USP17L18 USP17L17 CYB5R3 USP17L6P USP17L3 USP17L22 ABHD12 USP17L15 USP17L8 USP17L13	4.31e-08	1327	99	23	GO:0042175
GeneOntologyCellularComponent	presynapse	EPHB2 CACNA1A PRUNE2 CACNA1C SH3GL1 SH3GL3 GLRA3 PPFIA3 PFN1 MYOF GLRA1 CNTN5 NECTIN1 S1PR4	7.26e-05	886	99	14	GO:0098793
GeneOntologyCellularComponent	presynaptic membrane	EPHB2 CACNA1A CACNA1C GLRA3 GLRA1 CNTN5 NECTIN1	3.50e-04	277	99	7	GO:0042734
MousePheno	increased trophectoderm apoptosis	USP17L2 USP17L15 USP17L13	6.33e-06	8	69	3	MP:0012119
MousePheno	muscle spasm	CACNA1A RELN GLRA1 SLC7A10 DYNC1H1	1.12e-05	60	69	5	MP:0000743
MousePheno	muscle twitch	CACNA1A RELN GLRA1 SLC7A10 DYNC1H1	1.54e-05	64	69	5	MP:0009046
Domain	HABP4_PAI-RBP1	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	8.51e-31	16	101	14	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	8.51e-31	16	101	14	IPR006861
Domain	UCH	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP15 USP17L8 USP17L13	9.77e-28	71	101	19	PF00443
Domain	USP_2	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP15 USP17L8 USP17L13	9.77e-28	71	101	19	PS00973
Domain	USP_3	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP15 USP17L8 USP17L13	1.32e-27	72	101	19	PS50235
Domain	USP_dom	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP15 USP17L8 USP17L13	1.32e-27	72	101	19	IPR028889
Domain	Peptidase_C19_UCH	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP15 USP17L8 USP17L13	1.32e-27	72	101	19	IPR001394
Domain	USP_CS	USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP15 USP17L8 USP17L13	1.76e-26	66	101	18	IPR018200
Domain	USP_1	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP15 USP17L8 USP17L13	5.86e-26	70	101	18	PS00972
Domain	Ricin_B_lectin	GALNTL6 GALNT10 GALNT3 GALNT6 GALNT4	2.04e-07	25	101	5	PF00652
Domain	RICIN	GALNTL6 GALNT10 GALNT3 GALNT6 GALNT4	3.73e-07	28	101	5	SM00458
Domain	RICIN_B_LECTIN	GALNTL6 GALNT10 GALNT3 GALNT6 GALNT4	3.73e-07	28	101	5	PS50231
Domain	Ricin_B_lectin	GALNTL6 GALNT10 GALNT3 GALNT6 GALNT4	5.36e-07	30	101	5	IPR000772
Domain	Glycos_transf_2	GALNTL6 GALNT10 GALNT3 GALNT6 GALNT4	5.36e-07	30	101	5	PF00535
Domain	Glyco_trans_2-like	GALNTL6 GALNT10 GALNT3 GALNT6 GALNT4	5.36e-07	30	101	5	IPR001173
Domain	Spectrin_alpha_SH3	SH3GL1 SH3GL3 BCAR1	6.66e-05	15	101	3	IPR013315
Domain	Glycine_rcpt_A	GLRA3 GLRA1	1.73e-04	4	101	2	IPR008127
Domain	VDCC_a1su_IQ	CACNA1A CACNA1C	5.97e-04	7	101	2	IPR014873
Domain	GPHH	CACNA1A CACNA1C	5.97e-04	7	101	2	PF16905
Domain	GPHH_dom	CACNA1A CACNA1C	5.97e-04	7	101	2	IPR031649
Domain	Ca_chan_IQ	CACNA1A CACNA1C	5.97e-04	7	101	2	SM01062
Domain	Ca_chan_IQ	CACNA1A CACNA1C	5.97e-04	7	101	2	PF08763
Domain	DHC_N1	DNAH2 DYNC1H1	7.94e-04	8	101	2	PF08385
Domain	Dynein_heavy_dom-1	DNAH2 DYNC1H1	7.94e-04	8	101	2	IPR013594
Domain	EF-hand-dom_pair	CACNA1C VSNL1 SPEF2 DGKG MINDY3 SPOCK3 HPCAL4	9.45e-04	287	101	7	IPR011992
Domain	-	GALNTL6 GALNT10 GALNT3 GALNT6	9.74e-04	81	101	4	3.90.550.10
Domain	VDCCAlpha1	CACNA1A CACNA1C	1.27e-03	10	101	2	IPR002077
Domain	Nucleotide-diphossugar_trans	GALNTL6 GALNT10 GALNT3 GALNT6	1.33e-03	88	101	4	IPR029044
Domain	Dynein_heavy_chain_D4_dom	DNAH2 DYNC1H1	2.53e-03	14	101	2	IPR024317
Domain	Dynein_HC_stalk	DNAH2 DYNC1H1	2.53e-03	14	101	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH2 DYNC1H1	2.53e-03	14	101	2	IPR013602
Domain	DHC_N2	DNAH2 DYNC1H1	2.53e-03	14	101	2	PF08393
Domain	MT	DNAH2 DYNC1H1	2.53e-03	14	101	2	PF12777
Domain	AAA_8	DNAH2 DYNC1H1	2.53e-03	14	101	2	PF12780
Domain	ATPase_dyneun-rel_AAA	DNAH2 DYNC1H1	2.53e-03	14	101	2	IPR011704
Domain	AAA_5	DNAH2 DYNC1H1	2.53e-03	14	101	2	PF07728
Pathway	REACTOME_RAS_PROCESSING	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.01e-31	45	83	19	MM15671
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP15 USP17L15 USP17L8 USP17L13	6.17e-20	191	83	20	MM15289
Pathway	REACTOME_DEUBIQUITINATION	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 ACTL6A USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP15 USP17L15 USP17L8 USP17L13	1.77e-18	262	83	21	MM15286
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP15 USP17L15 USP17L8 USP17L13	2.48e-17	221	83	19	M27578
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 ACTL6A USP17L18 USP17L17 USP17L3 USP17L22 USP15 USP17L15 USP17L8 USP17L13	4.42e-16	299	83	20	M27574
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P FGB USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.45e-15	318	83	20	MM15278
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L7 GALNTL6 USP17L21 GALNT10 USP17L4 USP17L2 USP17L12 GALNT3 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 ACTL6A USP17L18 TUBB1 NUP155 USP17L17 CNTN5 USP17L6P USP17L3 EEF1AKMT2 GALNT6 USP17L22 USP15 USP17L15 DYNC1H1 GALNT4 USP17L8 USP17L13	1.69e-11	1389	83	31	MM15307
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	GALNTL6 USP17L21 GALNT10 USP17L4 USP17L2 USP17L12 GALNT3 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 ACTL6A USP17L18 TUBB1 NUP155 USP17L17 CNTN5 USP17L3 EEF1AKMT2 GALNT6 USP17L22 USP15 USP17L15 DYNC1H1 GALNT4 USP17L8 USP17L13	4.07e-10	1475	83	30	M19806
Pathway	KEGG_O_GLYCAN_BIOSYNTHESIS	GALNTL6 GALNT10 GALNT3 GALNT6 GALNT4	7.95e-07	30	83	5	M6929
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	GALNTL6 GALNT10 GALNT3 GALNT6 GALNT4	2.65e-05	60	83	5	MM15636
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	GALNTL6 GALNT10 GALNT3 GALNT6 GALNT4	3.12e-05	62	83	5	M546
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	GALNTL6 GALNT10 GALNT3 GALNT6 GALNT4	4.53e-04	109	83	5	MM15164
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	GALNTL6 GALNT10 GALNT3 GALNT6 GALNT4	4.93e-04	111	83	5	M27416
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.98e-47	21	104	19	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.98e-47	21	104	19	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.98e-47	21	104	19	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.98e-47	21	104	19	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.98e-47	21	104	19	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.98e-47	21	104	19	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.91e-46	22	104	19	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	8.01e-45	24	104	19	8995226
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.33e-44	25	104	19	21115691
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.23e-43	26	104	19	35816173
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.59e-43	33	104	20	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.28e-43	34	104	20	20403174
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.28e-43	34	104	20	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.28e-43	34	104	20	20388806
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.28e-43	34	104	20	14699124
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.28e-43	34	104	20	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.28e-43	34	104	20	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.28e-43	34	104	20	20368735
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.28e-43	34	104	20	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.28e-43	34	104	20	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.28e-43	34	104	20	11941478
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.28e-43	34	104	20	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.28e-43	34	104	20	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.46e-42	35	104	20	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.46e-42	35	104	20	21239494
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.28e-42	36	104	20	20147298
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.73e-42	29	104	19	32527007
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.13e-42	37	104	20	20228808
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.39e-36	50	104	19	31806660
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	2.17e-19	10	104	8	24207026
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	2.38e-18	12	104	8	24695638
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L7 CACNA1C USP17L21 MAGEB2 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 ACSBG2 USP17L22 PRDM14 USP17L15 USP17L8 USP17L13	4.44e-18	674	104	23	37196079
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	1.44e-17	14	104	8	11793228
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	3.57e-16	19	104	8	28067227
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP15 USP17L15 USP17L8	2.93e-12	81	104	9	12838346
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17	7.42e-08	119	104	7	28625976
Pubmed	Embryonic demise caused by targeted disruption of a cysteine protease Dub-2.	USP17L2 USP17L15 USP17L13	1.04e-07	4	104	3	22984479
Pubmed	The cell-layer- and cell-type-specific distribution of GalNAc-transferases in the ocular surface epithelia is altered during keratinization.	GALNT3 GALNT6 GALNT4	2.59e-07	5	104	3	12506059
Pubmed	DNA sequence and analysis of human chromosome 8.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L8	3.35e-07	48	104	5	16421571
Pubmed	Overexpression of Galnt3 in chondrocytes resulted in dwarfism due to the increase of mucin-type O-glycans and reduction of glycosaminoglycans.	GALNT10 GALNT3 GALNT6 GALNT4	5.29e-07	22	104	4	25107907
Pubmed	Loss of the disease-associated glycosyltransferase Galnt3 alters Muc10 glycosylation and the composition of the oral microbiome.	GALNT10 GALNT3 GALNT6 GALNT4	7.66e-07	24	104	4	31882545
Pubmed	Galnt11 regulates kidney function by glycosylating the endocytosis receptor megalin to modulate ligand binding.	GALNT10 GALNT3 GALNT6 GALNT4	7.66e-07	24	104	4	31740596
Pubmed	Diverse spatial expression patterns of UDP-GalNAc:polypeptide N-acetylgalactosaminyl-transferase family member mRNAs during mouse development.	GALNT10 GALNT3 GALNT4	1.44e-06	8	104	3	11159923
Pubmed	Galnt1 is required for normal heart valve development and cardiac function.	GALNT10 GALNT3 GALNT6 GALNT4	4.13e-06	36	104	4	25615642
Pubmed	O-glycosylation modulates integrin and FGF signalling by influencing the secretion of basement membrane components.	GALNT10 GALNT3 GALNT6 GALNT4	6.35e-06	40	104	4	22643896
Pubmed	Phosphatidylinositol 4-kinase IIα function at endosomes is regulated by the ubiquitin ligase Itch.	SH3GL1 MYOF USP15	7.27e-06	13	104	3	23146885
Pubmed	Characterization of the glycinergic input to bipolar cells of the mouse retina.	GLRA3 GLRA1	8.86e-06	2	104	2	16420443
Pubmed	L-type calcium channels contribute to the tottering mouse dystonic episodes.	CACNA1A CACNA1C	8.86e-06	2	104	2	9882694
Pubmed	Probing glycine receptor stoichiometry in superficial dorsal horn neurones using the spasmodic mouse.	GLRA3 GLRA1	8.86e-06	2	104	2	21486794
Pubmed	Phosphorylation of α3 glycine receptors induces a conformational change in the glycine-binding site.	GLRA3 GLRA1	8.86e-06	2	104	2	23834509
Pubmed	Isolation of two human cDNAs, HLP3 and HLP4, homologous to the neuron-specific calcium-binding protein genes.	VSNL1 HPCAL4	8.86e-06	2	104	2	10520747
Pubmed	Diltiazem inhibits SARS-CoV-2 cell attachment and internalization and decreases the viral infection in mouse lung.	CACNA1C ACE2	8.86e-06	2	104	2	35176124
Pubmed	ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production.	PFN1 ACE2	8.86e-06	2	104	2	22693641
Pubmed	Associations of Variants in the CACNA1A and CACNA1C Genes With Longitudinal Blood Pressure Changes and Hypertension Incidence: The GenSalt Study.	CACNA1A CACNA1C	8.86e-06	2	104	2	27418245
Pubmed	Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3.	GALNT3 GALNT6	8.86e-06	2	104	2	31932717
Pubmed	The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression.	GALNT3 GALNT6	8.86e-06	2	104	2	31071912
Pubmed	A Selectivity Filter Gate Controls Voltage-Gated Calcium Channel Calcium-Dependent Inactivation.	CACNA1A CACNA1C	8.86e-06	2	104	2	30733149
Pubmed	ACE2 and AT4R are present in diseased human blood vessels.	ACE2 LNPEP	8.86e-06	2	104	2	18502721
Pubmed	Multifunctional basic motif in the glycine receptor intracellular domain induces subunit-specific sorting.	GLRA3 GLRA1	8.86e-06	2	104	2	19959465
Pubmed	Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis.	FOXE1 TPO USP15	1.41e-05	16	104	3	38750011
Pubmed	A pilot proteomic study with a prospective cohort suspected to develop preeclampsia.	RELN FGB	2.65e-05	3	104	2	32472113
Pubmed	Association study between polymorphisms in the CACNA1A, CACNA1C, and CACNA1H genes and drug-resistant epilepsy in the Chinese Han population.	CACNA1A CACNA1C	2.65e-05	3	104	2	26216687
Pubmed	Loss of calcium channels in the cerebellum of the ataxic and epileptic stargazer mutant mouse.	CACNA1A CACNA1C	2.65e-05	3	104	2	19422811
Pubmed	Effects of thyrotropin releasing hormone on cerebellar mutant mice--a kinesiological comparison between rolling mouse Nagoya, weaver and reeler.	CACNA1A RELN	2.65e-05	3	104	2	6811784
Pubmed	Diversity of glycine receptors in the mouse retina: localization of the alpha4 subunit.	GLRA3 GLRA1	2.65e-05	3	104	2	17154252
Pubmed	Glycinergic input of small-field amacrine cells in the retinas of wildtype and glycine receptor deficient mice.	GLRA3 GLRA1	2.65e-05	3	104	2	17920294
Pubmed	Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation.	CACNA1A CACNA1C	2.65e-05	3	104	2	26507659
Pubmed	Truncation of murine CaV1.2 at Asp 1904 increases CaV1.3 expression in embryonic atrial cardiomyocytes.	CACNA1A CACNA1C	2.65e-05	3	104	2	23338940
Pubmed	Association of single nucleotide polymorphisms in CACNA 1A/CACNA 1C/CACNA 1H calcium channel genes with diabetic peripheral neuropathy in Chinese population.	CACNA1A CACNA1C	2.65e-05	3	104	2	29581247
Pubmed	TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology.	FOXE1 TPO TUBB1	3.84e-05	22	104	3	30446499
Pubmed	Glycinergic input of widefield, displaced amacrine cells of the mouse retina.	GLRA3 GLRA1	5.29e-05	4	104	2	19528249
Pubmed	Expression and mRNA splicing of glycine receptor subunits and gephyrin during neuronal differentiation of P19 cells in vitro, studied by RT-PCR and immunocytochemistry.	GLRA3 GLRA1	5.29e-05	4	104	2	9051263
Pubmed	EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia.	SH3GL1 SH3GL3	5.29e-05	4	104	2	9122235
Pubmed	Activation of glycine receptor phase-shifts the circadian rhythm in neuronal activity in the mouse suprachiasmatic nucleus.	GLRA3 GLRA1	5.29e-05	4	104	2	21486797
Pubmed	Synaptojanin and Endophilin Mediate Neck Formation during Ultrafast Endocytosis.	SH3GL1 SH3GL3	5.29e-05	4	104	2	29953872
Pubmed	A protein phosphatase 2calpha-Ca2+ channel complex for dephosphorylation of neuronal Ca2+ channels phosphorylated by protein kinase C.	CACNA1A CACNA1C	5.29e-05	4	104	2	15728831
Pubmed	Central noradrenaline metabolism in cerebellar ataxic mice.	CACNA1A RELN	5.29e-05	4	104	2	6123371
Pubmed	Endophilin-A coordinates priming and fusion of neurosecretory vesicles via intersectin.	SH3GL1 SH3GL3	5.29e-05	4	104	2	32152276
Pubmed	Alpha subunit-dependent glycine receptor clustering and regulation of synaptic receptor numbers.	GLRA3 GLRA1	5.29e-05	4	104	2	28883437
Pubmed	Expression and protein-binding studies of the EEN gene family, new interacting partners for dynamin, synaptojanin and huntingtin proteins.	SH3GL1 SH3GL3	5.29e-05	4	104	2	10816441
Pubmed	Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature.	CACNA1A CACNA1C	5.29e-05	4	104	2	21788606
Pubmed	Genomic organization and chromosomal localization of three members of the UDP-N-acetylgalactosamine: polypeptide N-acetylgalactosaminyltransferase family.	GALNT3 GALNT4	5.29e-05	4	104	2	9592121
Pubmed	LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis.	SH3GL1 SH3GL3	5.29e-05	4	104	2	22998870
Pubmed	G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels.	CACNA1A CACNA1C	5.29e-05	4	104	2	15953418
Pubmed	cDNA cloning and expression of a novel UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase.	GALNT3 GALNT4	8.80e-05	5	104	2	9153242
Pubmed	Alix (ALG-2-interacting protein X), a protein involved in apoptosis, binds to endophilins and induces cytoplasmic vacuolization.	SH3GL1 SH3GL3	8.80e-05	5	104	2	12034747
Pubmed	Identification and characterization of EBP, a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN fusion protein.	SH3GL1 SH3GL3	8.80e-05	5	104	2	14551139
Pubmed	Identification of a cardiac isoform of the murine calcium channel alpha1C (Cav1.2-a) subunit and its preferential binding with the beta2 subunit.	CACNA1A CACNA1C	8.80e-05	5	104	2	16787652
Pubmed	Developmental regulation of glycine receptors at efferent synapses of the murine cochlea.	GLRA3 GLRA1	8.80e-05	5	104	2	21850450
Pubmed	Antinociceptive effect of different types of calcium channel inhibitors and the distribution of various calcium channel alpha 1 subunits in the dorsal horn of spinal cord in mice.	CACNA1A CACNA1C	8.80e-05	5	104	2	15451373
Pubmed	Upregulation of Parkin in endophilin mutant mice.	SH3GL1 SH3GL3	8.80e-05	5	104	2	25471590
Pubmed	Modulation of chromatin position and gene expression by HDAC4 interaction with nucleoporins.	CACNA1C NUP155	8.80e-05	5	104	2	21464227
Pubmed	Endophilin-A Deficiency Induces the Foxo3a-Fbxo32 Network in the Brain and Causes Dysregulation of Autophagy and the Ubiquitin-Proteasome System.	SH3GL1 SH3GL3	8.80e-05	5	104	2	27720640
Pubmed	Personalized copy number and segmental duplication maps using next-generation sequencing.	POTEB3 USP17L2	8.80e-05	5	104	2	19718026
Pubmed	Functional disorders of the sympathetic nervous system in mice lacking the alpha 1B subunit (Cav 2.2) of N-type calcium channels.	CACNA1A CACNA1C	8.80e-05	5	104	2	11296258
Pubmed	Native glycine receptor subtypes and their physiological roles.	GLRA3 GLRA1	8.80e-05	5	104	2	18721822
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	ATXN2L PFN1 MYOF PRRC2C USP15 DYNC1H1	1.25e-04	256	104	6	33397691
Pubmed	Binding properties of SH3 peptide ligands identified from phage-displayed random peptide libraries.	SH3GL1 SH3GL3	1.32e-04	6	104	2	9238627
Pubmed	The interaction between EEN and Abi-1, two MLL fusion partners, and synaptojanin and dynamin: implications for leukaemogenesis.	SH3GL1 SH3GL3	1.32e-04	6	104	2	10764144
Pubmed	Role of dynamin, synaptojanin, and endophilin in podocyte foot processes.	SH3GL1 SH3GL3	1.32e-04	6	104	2	23187129
Cytoband	4p16.1	USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.54e-25	79	104	15	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.74e-18	222	104	15	chr4p16
Cytoband	8p23.1	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.49e-06	154	104	6	8p23.1
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.64e-05	234	104	6	chr8p23
Cytoband	4q34.1	GALNTL6 GLRA3	3.31e-04	12	104	2	4q34.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4q34	GALNTL6 GLRA3 WDR17	3.69e-04	61	104	3	chr4q34
GeneFamily	Polypeptide N-acetylgalactosaminyltransferases	GALNTL6 GALNT10 GALNT3 GALNT6 GALNT4	9.62e-09	20	68	5	433
GeneFamily	Glycine receptors	GLRA3 GLRA1	1.38e-04	5	68	2	868
GeneFamily	N-BAR domain containing	SH3GL1 SH3GL3	8.98e-04	12	68	2	1289
Coexpression	MADAN_DPPA4_TARGETS	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	9.99e-29	86	101	19	MM1312
Coexpression	GERY_CEBP_TARGETS	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 SH3GL3 USP17L5 USP17L10 USP17L19 PPP1R15A USP17L18 USP17L17 USP17L6P USP17L3 GPCPD1 USP17L22 USP17L15 USP17L8 USP17L13	2.69e-28	160	101	22	MM1155
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.37e-26	112	101	19	MM1095
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L7 USP17L21 USP17L4 LZTR1 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 BCAR1 PPP1R15A USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.57e-15	647	101	22	MM981
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 BCAR1 TIPARP USP17L18 MINDY3 USP17L17 LNPEP USP17L6P USP17L3 USP17L22 ABHD12 USP17L15 USP17L8 USP17L13	1.92e-12	1072	101	24	MM1031
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L7 USP17L21 USP17L4 LZTR1 USP17L2 USP17L12 GALNT3 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 BCAR1 PPP1R15A TIPARP USP17L18 USP17L17 USP17L6P USP17L3 C1S USP17L22 USP17L15 USP17L8 USP17L13	4.68e-12	1226	101	25	MM979
Coexpression	BRUINS_UVC_RESPONSE_LATE	USP17L7 CACNA1C USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 NECTIN1 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.77e-09	1198	101	21	MM1062
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNTL6 CACNA1A PRUNE2 ABCA12 LRP1B SPOCK3 CNTN5 CDH6	7.14e-10	139	96	8	a1945b07f177cde40e7eea03a19236ce76165857
ToppCell	droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 GALNT3 ITGAX SLC6A6 MYOF CHD5 GPCPD1 ABHD12	7.13e-09	186	96	8	f1aa0c58336d23bcbe52a59e7af954d20085bdb6
ToppCell	droplet-Lung-nan-21m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 GALNT3 ITGAX SLC6A6 MYOF CHD5 GPCPD1 ABHD12	7.13e-09	186	96	8	8f77e552e613b6e124443c7f6ef5c1316a5ff8db
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNTL6 CACNA1A RELN LRP1B POTEC SPOCK3 CNTN5	1.23e-08	128	96	7	91072ca56bce2c552a95edd67e17f43d8cc1de95
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	GALNTL6 CACNA1A MAGEB2 RELN DNAH2 SPOCK3 CNTN5	3.07e-08	146	96	7	c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNTL6 CACNA1A RELN GLRA3 LRP1B SPOCK3 CNTN5	3.70e-08	150	96	7	0205318a870e091add66ee4305747dda9f51510d
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 GALNT3 ITGAX SLC6A6 MYOF CHD5 ABHD12	1.55e-07	185	96	7	afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 GALNT3 ITGAX SLC6A6 MYOF CHD5 ABHD12	1.55e-07	185	96	7	775b72319ef6acffd2c9a74293b9c1bccea33f42
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	EPHB2 GALNTL6 CACNA1C RELN LRP1B SPOCK3 CNTN5	1.61e-07	186	96	7	8915436d09775f2828a7678af203b1082b36e21c
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	VSNL1 KRT32 ABCA12 SLC6A6 MYOF SPOCK3 NECTIN1	2.07e-07	193	96	7	7c34abdcb8839b9fb25457a79af6c5e7b9714b21
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNTL6 CACNA1A RELN LRP1B SPOCK3 CNTN5	8.31e-07	148	96	6	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	Basal_cells-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	VSNL1 KRT32 ABCA12 LRP1B SPOCK3 NECTIN1	1.09e-06	155	96	6	30accc72a6a914ae0c4d52b373ea1c9a98efbf22
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	GALNTL6 CACNA1A RELN GLRA3 SPOCK3 CNTN5	1.46e-06	163	96	6	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	VSNL1 KRT32 SLC6A6 MYOF SPOCK3 NECTIN1	1.99e-06	172	96	6	e9095c3dac66cf93d31f5f88364b565abacb1e2d
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FOXE1 VSNL1 ABCA12 MYOF SPOCK3 NECTIN1	2.59e-06	180	96	6	535a890bde0d978b461c2d4c571529b585c76b21
ToppCell	droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 GALNT3 ITGAX SLC6A6 MYOF ABHD12	2.68e-06	181	96	6	8fcdab61fad2efd324d2b27c58f5a594f1dc15de
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 GALNT3 ITGAX MYOF CHD5 ABHD12	2.77e-06	182	96	6	3dec003bad0f3716cf8163861a9d4302a7d6df8c
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 GALNT3 ITGAX SLC6A6 MYOF ABHD12	2.77e-06	182	96	6	be48ce85991bceeff938ba080e6bf9cc62176b05
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	CACNA1A PRUNE2 CACNA1C DGKG MYOF CDH6	2.85e-06	183	96	6	818fd886e0188091310825f9145fa53328f2c979
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	CACNA1A PRUNE2 CACNA1C DGKG MYOF CDH6	2.85e-06	183	96	6	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRUNE2 GALNT3 ITGAX MYOF CHD5 ABHD12	2.95e-06	184	96	6	15ea746c77785120f69f9ab370fb7eb9b70692f8
ToppCell	droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRUNE2 GALNT3 ITGAX MYOF CHD5 ABHD12	2.95e-06	184	96	6	bd5e8fc453a6393b8778734a2c3c2f1281769bcd
ToppCell	droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRUNE2 GALNT3 ITGAX MYOF CHD5 ABHD12	3.44e-06	189	96	6	98f517af255ef234eefc3ed7e6c1d63331ab8af0
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 ITGAX SLC6A6 MYOF GPCPD1 ABHD12	3.44e-06	189	96	6	287e59104687fe1665232c52993889f0f2c97f17
ToppCell	droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRUNE2 GALNT3 ITGAX MYOF CHD5 ABHD12	3.44e-06	189	96	6	f7e9b6e6a4de297b660a5b6c9a62f860c147185e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSNL1 GLRA3 PPFIA3 CHD5 CNTN5 HPCAL4	3.88e-06	193	96	6	461919ab422bc9d1fcff7a3a4757c75239041d7e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSNL1 GLRA3 PPFIA3 CHD5 CNTN5 HPCAL4	3.88e-06	193	96	6	0dd810ad900d3e586551622b2c1de39d76fd6a7f
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 CACNA1C DGKG LRP1B CHD5 CDH6	4.24e-06	196	96	6	9830fb3da7a60f65ad463e9054bb77c06b025e4d
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	PPP1R15A ITGAX PRRC2C GPCPD1 USP15 DYNC1H1	4.49e-06	198	96	6	61ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FOXE1 VSNL1 SLC6A6 MYOF NECTIN1 FOXD1	4.49e-06	198	96	6	fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GALNTL6 RELN VSNL1 CHD5 CNTN5 HPCAL4	4.76e-06	200	96	6	2f481e2fd248c02a5aa2e0248c16808df142fed2
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GALNTL6 RELN VSNL1 CHD5 CNTN5 HPCAL4	4.76e-06	200	96	6	bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GALNTL6 RELN VSNL1 CHD5 CNTN5 HPCAL4	4.76e-06	200	96	6	dc674124475edf83908b51a4e1454bc2dc4f06fa
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|kidney / Disease (COVID-19 only), tissue and cell type	GALNTL6 CACNA1A RELN SPOCK3 CNTN5	1.28e-05	139	96	5	64c35411bbe67acb5010dadc4b0b1be0f8b17737
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	GALNTL6 CACNA1A RELN SPOCK3 CNTN5	2.44e-05	159	96	5	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 GLRA3 LRP1B C1S WDR17	2.52e-05	160	96	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 GLRA3 LRP1B C1S WDR17	2.52e-05	160	96	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	PRUNE2 CACNA1C DGKG ACSBG2 CDH6	2.59e-05	161	96	5	64891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C VSNL1 LRP1B WDR17 CDH6	3.36e-05	170	96	5	5570c0e825bca77613bf0ebde620cf744fa1cb84
ToppCell	LV-13._Vascular_Smooth_Muscle\|LV / Chamber and Cluster_Paper	CACNA1A PRUNE2 CACNA1C DGKG CDH6	3.46e-05	171	96	5	e99ecae66530d1ae09330cee408c8f3950b87e67
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	PRUNE2 CACNA1C DGKG CHD5 CDH6	3.65e-05	173	96	5	a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc
ToppCell	NS-critical-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TPO CACNA1C FAM81B SPEF2 DNAH2	3.97e-05	176	96	5	b794275fdd757b8fa2108e3c867f23da2649146d
ToppCell	AT1-AT2_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	EPHB2 GALNT10 TUBB1 CDH6 HPCAL4	3.97e-05	176	96	5	f86832cfeff5b3cfffe4455c1b96a1420d48ba1e
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1\|TCGA-Liver / Sample_Type by Project: Shred V9	IFT140 GALNT3 SLC6A6 MYOF CDH6	4.19e-05	178	96	5	51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A PRUNE2 RELN VSNL1 ITGAX	4.41e-05	180	96	5	6ac62bf1251978c8c12e715f7b73144fca619794
ToppCell	droplet-Lung-nan-3m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 ITGAX SLC6A6 MYOF ABHD12	4.77e-05	183	96	5	ec3c05b9ce1e0fbb720e0dea41f1e28fd3fd878f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GALNTL6 RELN ABCA12 PKD1L2 LRP1B	4.90e-05	184	96	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GALNTL6 RELN ABCA12 PKD1L2 LRP1B	4.90e-05	184	96	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GALNTL6 RELN ABCA12 PKD1L2 LRP1B	4.90e-05	184	96	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRUNE2 GALNT3 ITGAX MYOF ABHD12	4.90e-05	184	96	5	8fa30789c9d583188667cf375d2218e392dd40bc
ToppCell	droplet-Lung-nan-3m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 ITGAX SLC6A6 MYOF ABHD12	4.90e-05	184	96	5	3261d767d5e3d9e9fbac22ad73ca14e44beed89c
ToppCell	droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRUNE2 GALNT3 ITGAX MYOF ABHD12	5.03e-05	185	96	5	4bee178ede12f56ba5f5bec44a03dc2a62c50137
ToppCell	droplet-Heart-4Chambers-21m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A RELN SH3GL3 RBP2 EXOC6B	5.03e-05	185	96	5	bb5a4cf93534b9bcd0923f314c389d571e91e7f8
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A PRUNE2 RELN VSNL1 DGKG	5.16e-05	186	96	5	d1d01ce46e62944aa9864eda47e8401b5f0d2bdc
ToppCell	droplet-Lung-nan-18m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 GALNT3 ITGAX MYOF ABHD12	5.29e-05	187	96	5	f0c6e53035b00772377c4d5f761b4d11026b911a
ToppCell	droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 GALNT3 ITGAX MYOF ABHD12	5.29e-05	187	96	5	f20e7a1751694390f535ffb27b97e887220f8695
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A PRUNE2 RELN VSNL1 DGKG	5.29e-05	187	96	5	1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C DGKG BCAR1 MYOF CDH6	5.29e-05	187	96	5	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRUNE2 ITGAX SLC6A6 MYOF ABHD12	5.56e-05	189	96	5	b2542b6fcf7bc10d29158d42b03182a939ff135a
ToppCell	droplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 ITGAX SLC6A6 MYOF ABHD12	5.56e-05	189	96	5	6d24414ac6bd4f03f7a5ad3a6eba51d549a7b112
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A PRUNE2 RELN VSNL1 DGKG	5.56e-05	189	96	5	f57200c93d39c9bce1adba0a6a1c178c028dd86b
ToppCell	droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRUNE2 ITGAX SLC6A6 MYOF ABHD12	5.70e-05	190	96	5	da58227565ad6a690828dd8554dd3670222f8582
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 CACNA1C DGKG MYOF CDH6	5.85e-05	191	96	5	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	EPHB2 RELN LRP1B MYOF CNTN5	5.85e-05	191	96	5	156b467187331ac6ca390d6ca861d9670bb7b956
ToppCell	Basal_cells-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	VSNL1 KRT32 SPOCK3 NECTIN1 CDH6	5.85e-05	191	96	5	a98915bad9a4a61dd4cbca798914849b805f4a19
ToppCell	facs-Brain_Non-Myeloid-Striatum\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3GL3 SPOCK3 CNTN5 WDR17 ABHD12	6.14e-05	193	96	5	d8ccfb780a75bdf9141f41fb29a076958601ebb4
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A PRUNE2 RELN VSNL1 DGKG	6.14e-05	193	96	5	5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2\|World / Primary Cells by Cluster	GALNTL6 RELN VSNL1 SPOCK3 CHD5	6.30e-05	194	96	5	b42fd64b0fb95434a9e4e6586f31d26114a4074b
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10\|World / Primary Cells by Cluster	GALNTL6 RELN VSNL1 SPOCK3 CHD5	6.30e-05	194	96	5	81e7bc6516ab8d02ccd1c76a56a3533b788c27c8
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|lung / Disease (COVID-19 only), tissue and cell type	PRUNE2 CACNA1C VSNL1 DGKG CDH6	6.30e-05	194	96	5	5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A RELN SLC6A6 PRRC2C DYNC1H1	6.45e-05	195	96	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A RELN SLC6A6 PRRC2C DYNC1H1	6.45e-05	195	96	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 CACNA1C DGKG CDH6 HPCAL4	6.77e-05	197	96	5	cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 CACNA1C DGKG LRP1B CDH6	6.93e-05	198	96	5	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RELN MYOF C1S CDH6 FOXD1	7.10e-05	199	96	5	b9338b739162cd8e5661c9a4dcb41a31219b5723
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RELN MYOF C1S CDH6 FOXD1	7.10e-05	199	96	5	c972d3036151403f26fa9d6271520639c281ab84
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 VSNL1 DGKG MYOF CDH6	7.27e-05	200	96	5	f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCell	COVID-19-kidney-Mito-rich_Int\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNTL6 CACNA1A RELN POTEC	1.41e-04	122	96	4	a4220adb4e6055a599bd9bbf65d460fc4e68b543
ToppCell	COVID-19-kidney-Technical/muscle\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNTL6 CACNA1A LRP1B CNTN5	2.33e-04	139	96	4	13247bcb21c57c808657e0f543d6f134eeea7cc1
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FAM81B PPP1R15A TRIM52 EXOC6B	2.73e-04	145	96	4	c0894c738815ff54790caddb4bccfa1503fd555b
ToppCell	COVID-19-kidney-Technical/muscle\|kidney / Disease (COVID-19 only), tissue and cell type	GALNTL6 CACNA1A RELN CNTN5	2.95e-04	148	96	4	0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GALNTL6 RELN SPOCK3 CNTN5	2.95e-04	148	96	4	5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GALNTL6 RELN SPOCK3 CNTN5	3.27e-04	152	96	4	8ff5a178a8f3550d89a003c0858820aab3773386
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-Naive_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	IFT140 SPEF2 SLC7A10 KLHL17	3.52e-04	155	96	4	1020da8a2c30384d962fa204a030299fdfcbbf98
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GALNTL6 CACNA1A DGKG LRP1B	3.52e-04	155	96	4	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DGKG TRIM52 MYOF NECTIN1	3.61e-04	156	96	4	2ba838bc864c2c1767bcab7bb4d790af96b91387
ToppCell	droplet-Fat-Mat-18m-Epithelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GALNTL6 RBP2 ATP10B PPFIA3	3.61e-04	156	96	4	cfd7f56f3155db677684827607e9008e975dbe70
ToppCell	droplet-Fat-Mat-18m-Epithelial-epithelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GALNTL6 RBP2 ATP10B PPFIA3	3.61e-04	156	96	4	0d79b4172896574b00faf00e87254f68d76f5512
ToppCell	droplet-Fat-Mat-18m-Epithelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GALNTL6 RBP2 ATP10B PPFIA3	3.61e-04	156	96	4	f09150aacb6121f913648ed3918f9cd4f22c61f2
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	FOXE1 KRT32 NECTIN1 MROH7	3.78e-04	158	96	4	98712ed7e8e65e8c5ff9318cf0e0a04e271a055d
ToppCell	RV-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	CACNA1A PRUNE2 CACNA1C CDH6	3.97e-04	160	96	4	29c9b4770d0e73d59cffc7937b179484c76b6dcc
ToppCell	PND07-28-samps-Myeloid-Macrophage-macrophage-B\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	GALNT3 ITGAX GALNT6 ABHD12	3.97e-04	160	96	4	694bf1f1952bd8ab444819f533da24fa2b73f701
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D231\|Adult / Lineage, Cell type, age group and donor	PRUNE2 CACNA1C CHD5 CDH6	3.97e-04	160	96	4	d783d29150033e9181c0e30870070268fed3fd85
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	CACNA1A PRUNE2 CACNA1C CDH6	4.06e-04	161	96	4	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C DGKG CHD5 CDH6	4.26e-04	163	96	4	51dee6c21cbeca4e17d1cc386e203f0c403089e8
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRUNE2 CACNA1C PRDM14 CDH6	4.36e-04	164	96	4	e3983f655cdba308fb192182829f17bef99ce0ba
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	SH3GL3 DGKG CHD5 HPCAL4	4.46e-04	165	96	4	9795ce31689bc63f5a2d68725ef00b23a90c3846
ToppCell	LV-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	CACNA1A CACNA1C DGKG CDH6	4.46e-04	165	96	4	f37fd95adc95d7753cf6e55ae819976513c7ec77
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 ITGAX MYOF ABHD12	4.56e-04	166	96	4	b3d9b61847c6c96b8cb28b8a6aeda52f43c706ab
ToppCell	Basal_cells-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	FOXE1 EPHB2 VSNL1 NECTIN1	4.56e-04	166	96	4	aea2ae12e4746149ebc6da063ef694381c098f80
Drug	Dorzolamide hydrochloride [130693-82-2]; Up 200; 11uM; MCF7; HT_HG-U133A	EPHB2 RELN ATP10B TUBB1 SLC6A6 MYOF CHD5 NECTIN1	9.58e-07	199	87	8	3565_UP
Drug	Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	EPHB2 CACNA1A ATXN2L SH3GL3 SLC6A6 MYOF NECTIN1	9.62e-06	194	87	7	4169_DN
Drug	Primaquine diphosphate [63-45-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A	MAGEB2 RELN ATP10B PPP1R15A FGB ACSBG2 CDH6	9.94e-06	195	87	7	4845_UP
Drug	Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; PC3; HT_HG-U133A	PRUNE2 KRT32 ATP10B GLRA1 MROH7 FGB HPCAL4	1.03e-05	196	87	7	6754_UP
Drug	Dimethadione [695-53-4]; Up 200; 31uM; PC3; HT_HG-U133A	PRUNE2 GALNT3 MORN1 ATP10B ITGAX NECTIN1 SLC7A10	1.03e-05	196	87	7	4607_UP
Drug	Levodopa [59-92-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A	CACNA1A GALNT3 ATP10B SLC6A6 ACE2 ACSBG2 HPCAL4	1.06e-05	197	87	7	4394_UP
Drug	nifedipine; Up 200; 10uM; MCF7; HG-U133A	ATXN2L SH3GL3 MINDY3 CHD5 EXOC6B PRDM14 S1PR4	1.06e-05	197	87	7	335_UP
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A	CACNA1A ATXN2L MAGEB2 GALNT3 FGB CDH6 S1PR4	1.06e-05	197	87	7	2654_UP
Drug	Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; HL60; HT_HG-U133A	GALNT10 MORN1 DGKG ATP10B RRAGB ACSBG2 HPCAL4	1.06e-05	197	87	7	2380_UP
Drug	Domperidone maleate; Up 200; 7.4uM; MCF7; HT_HG-U133A	ATXN2L VSNL1 GALNT3 SPOCK3 GLRA1 FGB CDH6	1.13e-05	199	87	7	2655_UP
Drug	Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; HL60; HT_HG-U133A	ATXN2L MORN1 ATP10B SPOCK3 EXOC6B METTL16 CDH6	1.17e-05	200	87	7	2434_UP
Drug	manidipine	CACNA1A CACNA1C ACTL6A ACE2 FGB	3.21e-05	95	87	5	CID000004008
Drug	etheno-NAD	TPO RELN ACTL6A PFN1 ACE2	4.95e-05	104	87	5	CID005288160
Drug	protostrychnine	GLRA3 GLRA1	8.62e-05	4	87	2	CID005320746
Drug	7-nitroindoline	GLRA3 GLRA1	8.62e-05	4	87	2	CID013566747
Drug	SC-49648	GLRA3 GLRA1	8.62e-05	4	87	2	CID000195696
Drug	akuammiline	GLRA3 GLRA1	8.62e-05	4	87	2	CID005367018
Drug	N-methyl-THIP	GLRA3 GLRA1	8.62e-05	4	87	2	CID000134373
Drug	SC-48981	GLRA3 GLRA1	8.62e-05	4	87	2	CID000126573
Drug	iso-THAZ	GLRA3 GLRA1	8.62e-05	4	87	2	CID003047783
Drug	2-(phosphonomethyl)phenylalanine	GLRA3 GLRA1	8.62e-05	4	87	2	CID000383689
Drug	NSC381080	GLRA3 GLRA1	8.62e-05	4	87	2	CID000165497
Drug	SC-50132	GLRA3 GLRA1	8.62e-05	4	87	2	CID000195719
Drug	SR 42641	GLRA3 GLRA1	8.62e-05	4	87	2	CID000129049
Drug	Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; HL60; HT_HG-U133A	PPP1R15A TRIM52 TIPARP MINDY3 MYOF LNPEP	9.53e-05	192	87	6	2919_DN
Drug	Aconitine [302-27-2]; Up 200; 6.2uM; MCF7; HT_HG-U133A	EPHB2 MAGEB2 GLRA3 PPFIA3 FGB CDH6	1.01e-04	194	87	6	2776_UP
Drug	(R)-Propranolol hydrochloride [13071-11-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A	ATP10B PPP1R15A SLC6A6 MYOF SPOCK3 FGB	1.04e-04	195	87	6	3553_UP
Drug	genistein; Down 200; 1uM; MCF7; HG-U133A	ATXN2L MAGEB2 CHD5 PRDM14 CDH6 S1PR4	1.04e-04	195	87	6	268_DN
Drug	Pentetic acid [67-43-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A	SH3GL3 ATP10B MINDY3 MYOF ACSBG2 SLC7A10	1.07e-04	196	87	6	3387_UP
Drug	Niridazole [61-57-4]; Up 200; 18.6uM; HL60; HT_HG-U133A	RELN GALNT3 ATP10B RRAGB FGB METTL16	1.07e-04	196	87	6	2440_UP
Drug	Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; MCF7; HT_HG-U133A	PRUNE2 GALNT3 ATP10B SPOCK3 GLRA1 FGB	1.10e-04	197	87	6	4724_DN
Drug	Aminopurine, 6-benzyl [1214-39-7]; Up 200; 17.8uM; HL60; HT_HG-U133A	CACNA1A ATXN2L IFT140 SH3GL1 ATP10B FGB	1.10e-04	197	87	6	2351_UP
Drug	Dubinidine [22964-77-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A	GLRA3 ATP10B SLC6A6 SPOCK3 CHD5 CNTN5	1.10e-04	197	87	6	3554_UP
Drug	Estropipate [7280-37-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A	PRUNE2 ATXN2L DGKG SLC6A6 EXOC6B CDH6	1.10e-04	197	87	6	6068_UP
Drug	felodipine; Up 200; 10uM; MCF7; HG-U133A	CACNA1A ATXN2L SH3GL3 MINDY3 CHD5 EXOC6B	1.10e-04	197	87	6	337_UP
Drug	Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A	FOXE1 ATXN2L IFT140 MORN1 ATP10B PRDM14	1.10e-04	197	87	6	4507_UP
Drug	Butoconazole nitrate [32872-77-1]; Up 200; 8.4uM; HL60; HT_HG-U133A	MORN1 ATP10B SLC6A6 ACSBG2 METTL16 CDH6	1.10e-04	197	87	6	2427_UP
Drug	Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; PC3; HT_HG-U133A	ATXN2L SPOCK3 CNTN5 C1S CDH6 HPCAL4	1.10e-04	197	87	6	4100_UP
Drug	Theobromine [83-67-0]; Down 200; 22.2uM; HL60; HT_HG-U133A	IFT140 GALNT10 ITGAX MYOF GLRA1 CDH6	1.13e-04	198	87	6	2995_DN
Drug	Fluocinonide [356-12-7]; Up 200; 8uM; MCF7; HT_HG-U133A	PPFIA3 SLC6A6 MYOF SPOCK3 GLRA1 CDH6	1.13e-04	198	87	6	3414_UP
Drug	Amitryptiline hydrochloride [549-18-8]; Up 200; 12.8uM; MCF7; HT_HG-U133A	PRUNE2 ATXN2L MAGEB2 MORN1 SPOCK3 METTL16	1.13e-04	198	87	6	5453_UP
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	ATXN2L IFT140 LZTR1 PPFIA3 SLC6A6 MINDY3	1.13e-04	198	87	6	996_UP
Drug	6-thioguanine; Down 200; 10uM; MCF7; HG-U133A	KRT32 PPFIA3 TRIM52 MINDY3 CYB5R3 S1PR4	1.13e-04	198	87	6	642_DN
Drug	Bumetanide [28395-03-1]; Up 200; 11uM; HL60; HT_HG-U133A	CACNA1A ATXN2L DGKG PPP1R15A TUBB1 CNTN5	1.16e-04	199	87	6	2409_UP
Drug	Flutamide [13311-84-7]; Up 200; 14.4uM; PC3; HT_HG-U133A	ATXN2L SLC6A6 CHD5 CNTN5 NECTIN1 PRDM14	1.16e-04	199	87	6	4539_UP
Drug	N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; MCF7; HT_HG-U133A	EPHB2 VSNL1 ABCA12 PPP1R15A ACE2 CDH6	1.16e-04	199	87	6	6462_UP
Drug	Propylthiouracil [51-52-5]; Up 200; 23.4uM; HL60; HT_HG-U133A	VSNL1 GALNT3 ATP10B MYOF CNTN5 FGB	1.16e-04	199	87	6	2476_UP
Drug	Suxibuzone [27470-51-5]; Up 200; 9.2uM; HL60; HT_HG-U133A	GALNT3 DNAH2 ATP10B TUBB1 SLC6A6 EXOC6B	1.19e-04	200	87	6	2503_UP
Drug	Lindane	GLRA3 GLRA1	1.43e-04	5	87	2	DB00431
Drug	pleiocarpamine	GLRA3 GLRA1	1.43e-04	5	87	2	CID000558637
Drug	azetidine-3-carboxylic acid	GLRA3 GLRA1	1.43e-04	5	87	2	CID000093192
Drug	Cao C	GLRA3 GLRA1	1.43e-04	5	87	2	CID000166617
Drug	oxanilide	GLRA3 GLRA1	1.43e-04	5	87	2	CID000069288
Drug	iso-THAO	GLRA3 GLRA1	1.43e-04	5	87	2	CID000127199
Drug	ALX1393	GLRA3 GLRA1	1.43e-04	5	87	2	CID016078939
Drug	mafoprazine	GLRA3 GLRA1	1.43e-04	5	87	2	CID000071241
Drug	gevotroline	GLRA3 GLRA1	1.43e-04	5	87	2	CID000060546
Drug	THAZ	GLRA3 GLRA1	2.14e-04	6	87	2	CID000171289
Drug	thiomuscimol	GLRA3 GLRA1	2.14e-04	6	87	2	CID000005448
Drug	thio-THIP	GLRA3 GLRA1	2.14e-04	6	87	2	CID000656720
Drug	AC1L90PQ	GLRA3 GLRA1	2.14e-04	6	87	2	CID000436036
Drug	mV GABA	GLRA3 GLRA1	2.14e-04	6	87	2	CID000128435
Drug	caged glycine	GLRA3 GLRA1	2.14e-04	6	87	2	CID000192642
Drug	brometone	GLRA3 GLRA1	2.14e-04	6	87	2	CID000006424
Drug	minaxolone	GLRA3 GLRA1	2.14e-04	6	87	2	CID000071960
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.20e-38	46	99	20	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.28e-34	69	99	20	DOID:1682 (implicated_via_orthology)
Disease	response to angiotensin-converting enzyme inhibitor, Cough	GALNTL6 PKD1L2 EXOC6B	5.01e-04	46	99	3	EFO_0005325, HP_0012735
Disease	chronic kidney disease, Proteinuria	CACNA1A SH3GL3	6.01e-04	11	99	2	EFO_0003884, HP_0000093
Disease	Congenital Hypothyroidism	FOXE1 TPO	8.48e-04	13	99	2	C0010308
Disease	congenital hypothyroidism (implicated_via_orthology)	FOXE1 TPO	9.88e-04	14	99	2	DOID:0050328 (implicated_via_orthology)
Disease	platelet component distribution width	PRUNE2 CACNA1C ZMIZ1 TUBB1 PRRC2C CNTN5 CYB5R3 EEF1AKMT2 USP15	9.99e-04	755	99	9	EFO_0007984
Disease	susceptibility to hepatitis B infection measurement	CACNA1C MINDY3 WDR17	1.32e-03	64	99	3	EFO_0008405
Disease	short-term memory	GALNTL6 CACNA1C SH3GL3	2.77e-03	83	99	3	EFO_0004335
Disease	Involutional paraphrenia	CACNA1C RELN	3.18e-03	25	99	2	C1571983
Disease	Psychosis, Involutional	CACNA1C RELN	3.18e-03	25	99	2	C1571984
Disease	Involutional Depression	CACNA1C RELN	3.18e-03	25	99	2	C0011574

Protein segments in the cluster

Peptide	Gene	Start	Entry
NNNLYSWDDFMELGR	ACSBG2	191	Q5FVE4
GEDWNEVMYDGIKSQ	CACNA1A	666	O00555
QLMAEWGLDDVDYLF	CHD5	136	Q8TDI0
SGWNFLNYVTEEMVD	SLC7A10	246	Q9NS82
GQYENSEGGWMEDYD	BCAR1	651	P56945
YEEQGIGLQWENMYT	ABCA12	1226	Q86UK0
FQQMWISKQEYEEGG	ACTL6A	406	O96019
DDGGYRSSMWDQGDI	ATP10B	676	O94823
WDPNEMFKFNEENYG	ATXN2L	251	Q8WWM7
PQGFEVGYWKDMEQE	CNTN5	906	O94779
YETTFLEDQGGWELM	MROH7	921	Q68CQ1
MALAADGEVFAWGYN	RCBTB1	141	Q8NDN9
WDYGQGFVNEEMIRD	CYB5R3	246	P00387
GNYWTLDPESADMFD	FOXD1	196	Q16676
SFGYTMNDLIFEWQD	GLRA3	191	O75311
LNAEVMVWNDGEDSY	ITGAX	801	P20702
GGQEFWADLNAMNVY	TIPARP	306	Q7Z3E1
NAQGKDQMWYEDALA	ABHD12	151	Q8N2K0
QMLFQNGDKYDGDWV	MORN1	146	Q5T089
DAVLDQYSMWGNKFG	MINDY3	166	Q9H8M7
LNWAFEMYDLDGDGR	HPCAL4	101	Q9UM19
DFHAENDTIYWTDMG	LRP1B	1916	Q9NZR2
AGYDGNARLNDMWTI	LZTR1	191	Q8N653
EEIWEFLNMLGVYDG	MAGEB2	221	O15479
YETQAGDAMRGAFDW	GALNT10	276	Q86SR1
ILAYGDMNHEWVGND	PPFIA3	946	O75145
WYSEGAFNGNEKETM	KRT32	86	Q14532
LNQDDVWVNYFGGMG	DCAF12L2	411	Q5VW00
SGWEEVSGYDENMNT	EPHB2	41	P29323
NGMFFSTYDRDNDGW	FGB	401	P02675
TDDDRYSDLLMAWGQ	TPO	221	P07202
GWYFLATEVDDMCFN	METTL16	126	Q86W50
NDLWLNEGFATFMEY	LNPEP	481	Q9UIQ6
FLQLADYDWMTGDLG	EXOC6B	621	Q9Y2D4
DYDWMTGDLGNKASD	EXOC6B	626	Q9Y2D4
SDIFMWNYEDGGDLA	NUP155	121	O75694
NGGITWNLLMEIFYD	RELN	2601	P78509
AEDMADYGEGWNATT	PKD1L2	2061	Q7Z442
WGELETMQNEYQSGF	FAM81B	396	Q96LP2
NVGTWGDYDDSAFME	POTEB3	116	A0JP26
GMDYDRDGFVSLQEW	DGKG	231	P49619
DGMWDGNLSTYFDMN	GPCPD1	466	Q9NPB8
DLVAMDGWLYAVGGN	KLHL17	571	Q6TDP4
EDWNSVMYDGIMAYG	CACNA1C	706	Q13936
YIGSYDEEMEIWGGE	GALNT3	376	Q14435
TYDTGMEVWGGENLE	GALNT4	326	Q8N4A0
FEHIGTYDNQMEIWG	GALNT6	366	Q8NCL4
TYDNQMEIWGGENVE	GALNT6	371	Q8NCL4
EYGDTGEIWFGEESM	EEF1AKMT2	51	Q5JPI9
DYNLMDGDLGLISGW	C1S	556	P09871
SALGDKAYEWNDNEM	ACE2	626	Q9BYF1
WDMQAENIYNRLGED	DYNC1H1	1061	Q14204
MWNQFFLLEEYTGSD	CDH6	56	P55285
YINDGESVNLFEWMA	SDR42E2	276	A6NKP2
WEAVGMFSGDGEYID	DNAH2	1581	Q9P225
FGSNLWAQEYLRGMD	S1PR4	276	O95977
WAQYLESQGEMDAAL	IFT140	961	Q96RY7
YAMYNGQWDLGQEVL	FAM126B	246	Q8IXS8
MAADGDWQDFYEFQE	FEZ2	1	Q9UHY8
TAFENMTKDWNYLEG	KRBA2	41	Q6ZNG9
EAWGLLDDDDGMYGE	PPP1R15A	106	O75807
NVGAWGDYDDSAFME	POTEC	116	B2RU33
YEAQAGDAMRGAFDW	GALNTL6	271	Q49A17
QYMQAGLWFTGDEDI	SPEF2	1576	Q9C093
WIYGGDNLYDGIEDM	SLC6A6	481	P31641
EASWGDFEYDVMGQN	PRUNE2	2346	Q8WUY3
NQIDENWYEGMIHGE	SH3GL3	316	Q99963
YGDNSVMWEIFEDGH	PRDM14	296	Q9GZV8
MAGWNAYIDNLMADG	PFN1	1	P07737
YWALDPNAEDMFESG	FOXE1	126	O00358
SFGYTMNDLIFEWQE	GLRA1	186	P23415
DEGWAGAQMEVDYTE	PRRC2C	316	Q9Y520
HWYTSEGMDINEFGE	TUBB1	396	Q9H4B7
FEQDDWYEGLQRANM	WDR17	11	Q8IZU2
NGTWEMESNENFEGY	RBP2	6	P50120
LGDSGITNWDNVDYM	TRIM52	106	Q96A61
MGDDSLYLGGEWQFN	USP17L3	1	A6NCW0
TNQIDENWYEGMLDG	SH3GL1	336	Q99961
ENWYEGMLDGQSGFF	SH3GL1	341	Q99961
LNWAFNMYDLDGDGK	VSNL1	101	P62760
GYSDAEMDEQEEGGW	ZSCAN20	431	P17040
MGDDSLYLGGEWQFN	USP17L4	1	A6NCW7
MEDDSLYLGGEWQFN	USP17L18	1	D6R9N7
MEDDSLYLRGEWQFN	USP17L5	1	A8MUK1
MEEDSLYLGGEWQFN	USP17L21	1	D6R901
GFDSWDKYQMGDQNV	USP15	46	Q9Y4E8
MEEDSLYLGGEWQFN	USP17L13	1	C9JLJ4
MEEDSLYLGGEWQFN	USP17L19	1	D6RCP7
LWDCGGQDTFMENYF	RRAGB	121	Q5VZM2
MGDDSLYLGGEWQFN	USP17L1	1	Q7RTZ2
DSLGWMFNRLDTNYD	SPOCK3	251	Q9BQ16
MEEDSLYLGGEWQFN	USP17L12	1	C9JPN9
MEDDSLYLRGEWQFN	USP17L24	1	Q0WX57
MEDDSLYLGGDWQFN	USP17L7	1	P0C7H9
MEDDSLYLGGEWQFN	USP17L8	1	P0C7I0
MEDDSLYLRGEWQFN	USP17L6P	1	Q6QN14
MEDDSLYLGGEWQFN	USP17L22	1	D6RA61
MEDDSLYLGGEWQFN	USP17L15	1	C9J2P7
MEDDSLYLGGEWQFN	USP17L17	1	D6RBQ6
MEDDSLYLGGEWQFN	USP17L23	1	D6RBM5
MEDDSLYLGGEWQFN	USP17L2	1	Q6R6M4
MEDDSLYLGGEWQFN	USP17L20	1	D6RJB6
EGLEVDQYMWGILNA	ZMIZ1	791	Q9ULJ6
MEDDSLYLGGEWQFN	USP17L10	1	C9JJH3
MEDDSLYLGGEWQFN	USP17L11	1	C9JVI0
VYFSLSDEEEMWQAG	KIAA1958	531	Q8N8K9
AMEELQDQEGWEYAS	MYOF	1041	Q9NZM1
IEGFDGNWYLQRMDV	NECTIN1	251	Q15223